+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Home Newsletters Next Share

40 AND UNDER: The Silicon Valley biotech stars who are backing startups aiming to cure disease, prolong life, and fix the food system

Sep 6, 2018, 19:18 IST

Laura Deming, one of the youngest fund managers in the US, wants to create an antidote to aging.

Advertisement

An engineer by training, Mohammad Islam left a job with the CIA to fund big ideas "unlike anything we've seen before."

Advertisement

Blake Byers is an engineer, scientist, and entrepreneur who has been leading investments at Alphabet's venture arm GV since 2010.

Julie Grant is a triple threat in business and science, with degrees from Stanford, Cambridge, and Yale. She uses her academic expertise to help startups translate concepts into real products.

Julie Grant is a triple threat in business and science, with degrees from Stanford, Cambridge, and Yale. She uses her academic expertise to help startups translate concepts into real products.

Advertisement

An engineering junkie from his early days, Benjamin Tseng raised $60 million for a startup and now links investors with pioneering companies in China.

Dylan Morris takes his experience with his own diagnostic startup and applies it to support other companies attempting to cure disease.

Advertisement

A chemist by training with two successful biotech startups under her belt, Megan Blewett is betting on tools like CRISPR to revolutionize research and how we treat disease.

A chemist by training with two successful biotech startups under her belt, Megan Blewett is betting on tools like CRISPR to revolutionize research and how we treat disease.

John Melas-Kyriazi is helping one of the top investment firms in Silicon Valley make winning bets in the biotech sphere.

Advertisement

Racquel Bracken deferred med school for a drug-development consulting gig. Now she's backing companies that use the body to heal itself.

Michael Dixon supports entrepreneurs bringing together the field of medicine and enterprise software to make healthcare less messy.

Advertisement

Renata Quintini invests in ambitious startups that aim to help us to not only live longer but live well.

Francisco Gimenez uses his background in medicine and data to get us closer to a future in which drugs are living entities.

Advertisement

A partner at one of Silicon Valley's leading biotech hubs, Jun Axup picks the startups that get $250,000 and four months of hands-on training from accelerator IndieBio.

Graham Walmsley signed one of the largest Series A financing deals in biotech history.

Advertisement

Jennifer Kaehms, who earned her degree in bioengineering, helps recruit college students to become the top VCs of tomorrow.

Zal Bilimoria spent 10 years as a product manager at Microsoft, Google, Netflix, and LinkedIn before launching his own venture fund.

Advertisement

Dan Estes is an adviser to therapeutics companies, and has his eye on startups creating treatments he can clearly envision in the clinic.

Vineeta Agarwala is a physician, scientist, and GV investor who oversees product management at buzzy startup Flatiron Health.

Advertisement

Next Story

12 things everyone should have at home in case of a natural disaster

Copyright @ 2024. Times Internet Limited. All rights reserved.For reprint rights. Times Syndication Service.